1. Home
  2. TRSG vs RNXT Comparison

TRSG vs RNXT Comparison

Compare TRSG & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRSG
  • RNXT
  • Stock Information
  • Founded
  • TRSG 1996
  • RNXT 2012
  • Country
  • TRSG Singapore
  • RNXT United States
  • Employees
  • TRSG N/A
  • RNXT N/A
  • Industry
  • TRSG
  • RNXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRSG
  • RNXT Health Care
  • Exchange
  • TRSG NYSE
  • RNXT Nasdaq
  • Market Cap
  • TRSG 33.4M
  • RNXT 31.6M
  • IPO Year
  • TRSG 2024
  • RNXT 2021
  • Fundamental
  • Price
  • TRSG $1.92
  • RNXT $1.04
  • Analyst Decision
  • TRSG
  • RNXT Strong Buy
  • Analyst Count
  • TRSG 0
  • RNXT 1
  • Target Price
  • TRSG N/A
  • RNXT $9.00
  • AVG Volume (30 Days)
  • TRSG 3.4K
  • RNXT 226.9K
  • Earning Date
  • TRSG 12-31-2024
  • RNXT 03-31-2025
  • Dividend Yield
  • TRSG N/A
  • RNXT N/A
  • EPS Growth
  • TRSG N/A
  • RNXT N/A
  • EPS
  • TRSG N/A
  • RNXT N/A
  • Revenue
  • TRSG $14,441,864.00
  • RNXT N/A
  • Revenue This Year
  • TRSG N/A
  • RNXT N/A
  • Revenue Next Year
  • TRSG N/A
  • RNXT N/A
  • P/E Ratio
  • TRSG N/A
  • RNXT N/A
  • Revenue Growth
  • TRSG 9.34
  • RNXT N/A
  • 52 Week Low
  • TRSG $1.91
  • RNXT $0.77
  • 52 Week High
  • TRSG $11.78
  • RNXT $1.86
  • Technical
  • Relative Strength Index (RSI)
  • TRSG N/A
  • RNXT 32.70
  • Support Level
  • TRSG N/A
  • RNXT $1.00
  • Resistance Level
  • TRSG N/A
  • RNXT $1.18
  • Average True Range (ATR)
  • TRSG 0.00
  • RNXT 0.10
  • MACD
  • TRSG 0.00
  • RNXT -0.04
  • Stochastic Oscillator
  • TRSG 0.00
  • RNXT 8.00

About TRSG TUNGRAY TECHNOLOGIES INC

Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: